» Articles » PMID: 15850839

Mesenchymal Stem Cells Remain of Host Origin Even a Long Time After Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation

Overview
Journal Exp Hematol
Specialty Hematology
Date 2005 Apr 27
PMID 15850839
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Plasticity of hematopoietic stem cells (HSC) has gained major interest in stem cell research. In order to investigate whether HSC may differentiate into mesenchymal stem cells (MSC), we assessed chimerism in peripheral blood (PB), mononuclear cell fractions (MNC) of bone marrow, and MSC derived from bone marrow (BM) from 27 up to 4225 days after allogeneic transplantation.

Patients And Methods: We applied fluorescence in situ hybridization using X/Y gene probes in sex-mismatched and STR-PCR in sex-matched patients. MSC could have been generated in 27 of 55 bone marrow samples derived from 20 patients. Fifteen patients received peripheral blood stem cell transplants (PBSCT), including CD34-selected PBSCT in two. Five patients received bone marrow.

Results: While all patients had chimerism in PB and MNC of the BM, in all but one patient BM-derived MSC were of recipient origin. This single patient showed reproducibly MSC of donor origin in a frequency of 1% after having received a CD34-selected PBSCT. Looking at graft collections, MSCs were easily generated from BM specimens, while no MSC could be derived from PBSC samples.

Conclusion: Even though HSC have been found to differentiate into a variety of nonhematological cell types, they usually do not differentiate into MSC after allogeneic transplantation.

Citing Articles

IL-6 knockdown in a model of the human bone marrow, abrogates DNA damage induction in bystander cells post-chemotherapy induced cytokine release syndrome.

Asurappulige H, Ladomery M, Ruth Morse H Transl Oncol. 2024; 46:102030.

PMID: 38870677 PMC: 11222933. DOI: 10.1016/j.tranon.2024.102030.


Genotoxicity of cytokines at chemotherapy-induced 'storm' concentrations in a model of the human bone marrow.

Asurappulige H, Thomas A, Ruth Morse H Mutagenesis. 2023; 38(4):201-215.

PMID: 37326959 PMC: 10448863. DOI: 10.1093/mutage/gead018.


Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.

Haga C, Boregowda S, Booker C, Krishnappa V, Strivelli J, Cappelli E Cytotherapy. 2022; 25(4):362-368.

PMID: 36481320 PMC: 10006355. DOI: 10.1016/j.jcyt.2022.11.003.


The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation.

Peci F, Dekker L, Pagliaro A, van Boxtel R, Nierkens S, Belderbos M Bone Marrow Transplant. 2022; 57(9):1357-1364.

PMID: 35690693 PMC: 9187885. DOI: 10.1038/s41409-022-01728-0.


Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche.

Cevher Zeytin I, Alkan B, Ozdemir C, Uckan Cetinkaya D, Visal Okur F Stem Cells Transl Med. 2022; 11(3):310-321.

PMID: 35356978 PMC: 8969067. DOI: 10.1093/stcltm/szab019.